TANIMOTO SARINA (Chief Medical Officer) sold 3.9% of their position (50K shares) of ARS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $703.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/21/2025ACC: 0001415889-25-022638
Officer10% Owner· Chief Medical Officer
Since Nov 2022
-50K
Net shares
Net seller
$703.8K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
50K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−12.34K
Price / share
$14.03
Trade value
$173.13K
% of position
1.0%
8/19/2025
1.30M→1.29M
Common Stock
Indirect
Shares
−37.66K
Price / share
$14.09
Trade value
$530.63K
% of position
2.9%
8/20/2025
1.29M→1.25M
Total
Net shares
−50K
Net value
-$703.76K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/19/2025 | S · Sale | −12.34K | $14.03 | $173.13K | 1.0% | 1.30M | 1.29M |
| Common Stock Indirect | 8/20/2025 | S · Sale | −37.66K | $14.09 | $530.63K | 2.9% | 1.29M | 1.25M |
| Total | −50K | -$703.76K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned1.25M
Common Stock
IndirectShares owned8.86M
Total
10.11M indirect10.11M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.25M | Indirect |
| Common Stock | 8.86M | Indirect |
| Total | 10.11M | 10.11M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported